Part 2 — THC and Sleep: The Strongest Evidence We Have

What polysomnography, clinical trials, and large cohort studies tell us about THC's effects on sleep architecture

What THC Does to Your Brain During Sleep

THC is a potent partial agonist at CB1 cannabinoid receptors — the primary receptor in the brain and central nervous system. THC binds CB1 with a Ki of approximately 5–80 nM, making it a high-affinity ligand by any measure. CB1 receptors are heavily expressed in the locus coeruleus, hippocampus, basal ganglia, and cerebral cortex — all regions critically involved in sleep-wake regulation.

Through CB1 activation, THC increases noradrenaline (norepinephrine) release from the locus coeruleus. This heightened noradrenergic activity acts as a gatekeeper for REM sleep — it partitions sleep cycles and delays or suppresses REM onset. This mechanism is central to understanding THC's most consistently observed effect on sleep architecture: REM suppression.

REM Suppression: What It Means Clinically

REM sleep is the stage where most dreaming occurs — and where your brain processes emotional memories, consolidates learning, and performs critical neurological housekeeping. Suppressing it isn't inherently good or bad; the clinical implication depends entirely on the patient and their sleep complaint.

For patients whose primary problem is nightmares, PTSD-related sleep disturbances, or hyperactive dream states, THC's REM suppression may be genuinely therapeutic. This is a population where THC has arguably its strongest case in sleep medicine. For patients with other forms of insomnia — particularly those whose main complaint is waking during the night or non-restorative sleep — the picture is more complicated.

What Short-Term THC Use is Associated With

• Reduced sleep onset latency (falls asleep faster) — primarily with acute/short-term use

• Increased slow-wave sleep (deep NREM, stages N2/N3) — again more prominent acutely

• Significant REM sleep suppression (reduced time in REM, prolonged REM latency)

• Subjective sense of relaxation and improved bedtime wind-down in self-report data

• Reduced nightmares — makes THC particularly relevant for PTSD-associated sleep disorders

The 2025 systematic review and meta-analysis (Feige et al., Sleep Medicine Reviews) that examined 18 polysomnography studies summarized the field well: cannabis does not consistently alter sleep duration, latency, wake time, efficiency, or sleep staging across all populations and conditions. Early studies suggesting uniform benefit were based on small samples, high THC doses, and methodological limitations that more recent, better-designed studies have not replicated uniformly.

The honest clinical takeaway is this: THC clearly affects sleep architecture, particularly REM sleep, sleep onset, and nighttime relaxation — but the long-term picture is more nuanced than many marketing claims suggest. Dose, timing, tolerance, and individual physiology all matter tremendously.

That is exactly why Dr. Murse formulates differently.

Rather than focusing on hype or single cannabinoids alone, our Rest & Restore Evening Formula was intentionally designed around structured cannabinoid dosing, terpene synergy, and evidence-informed formulation philosophy using β-myrcene, linalool, and β-caryophyllene alongside cannabinoids to support nighttime wind-down and restorative routines more thoughtfully.

Because sleep is complex. And formulation should be too.

At Dr. Murse | CannabisDNP, we believe consumers deserve transparency, education, and formulations built with purpose — not just trends. The Formulator Is on the Label because accountability matters.